Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D deficiency is common in women with PCOS and linked to some metabolic problems, but not the main cause of their metabolic issues.

Most women with hirsutism have it because of PCOS, and they need long-term treatment including medication and hair removal to improve their condition.

AMH levels are higher in women with PCOS and can indicate the number of small follicles in their ovaries.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

A simple screening method found that 6.3% of women in a semiurban area in Sri Lanka have polycystic ovary syndrome, with most showing menstrual irregularities.

Eating fewer calories, less sugar and refined carbs, and more low-glycemic and omega-3 rich foods can help manage PCOS symptoms.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Melatonin improved mental health and metabolism in women with PCOS.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Rutin may help treat symptoms of polycystic ovary syndrome (PCOS) in rats.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Women with PCOS have higher levels of certain blood clotting factors, suggesting a greater risk of cardiovascular issues.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

Women with PCOS have more emotional and body image issues than healthy women.

PCOS lowers quality of life, causing issues like obesity, infertility, and menstrual problems.

Spironolactone effectively treats female pattern hair loss with few side effects.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Copper deficiency may cause hair loss, and treating it could involve nutrition and hormones.

Ayurvedic treatment helped improve PCOD symptoms and ultrasound results.